COVID Clinical Trial
Official title:
Searching for SARS-CoV 2 in Personal Protective Equipment in Physicians in a University Hospital
SARS-CoV-2 transmission is frequently occurring in hospital settings, with numerous reported
cases of nosocomial transmission highlighting the vulnerability of healthcare workers.
If products proved to be efficacious against COVID-19, why are so many HCW getting COVID-19?
Is it related to experience? Is it generated by the exhaustive job? Is there any degree of
relationship to stress? These questions are still without fully correct answers. Achieving
global benefits for HCW is still waiting.
Objective: To assess the extent of surface contamination PPE doctors (personal protective
equipment) with SARS-CoV-2, immediately after evaluating ill patients.
COVID-19 is a recently emerging disease, in which much scientific information is being
generated, but in which there are few certainties. This is due to work of poor methodological
quality, but also due to the fact that it is a recent infection, which has only been
developing for a few months. Given that most cases of infection in health personnel in the
workplace come from contamination with personal protective equipment, it is necessary to
determine there is any degree of contamination of PPE by the virus, as the critical areas
where it can be located in the PPE as well. That is why this investigation, when trying to
determine the location and degree of contamination of PPE by COVID-19, will allow the
implementation of exhaustive care that leads to greater care for health personnel.
Target population: patients with a diagnosis of COVID-19 in patients admitted to a service in
the General Ward and Intensive Care Unit or Coronary Unit of a University Hospital of
C.A.B.A- (Argentina) Accessible population of adults patients with a diagnosis of COVID-19
admitted to the CN / Intensive Care Unit / Coronary Unit, while the research is in progress.
Population Definition Criteria: PPE of medical personnel in contact with hospitalized
patients with SARS-CoV-2 positive swab, hospitalized in CM / UTI / UC wards.
Inclusion Criteria: Samples of personal protective equipment of health personnel who have
been in contact with patients with positive viral RNA results in RT-real time PCR (rtPCR +)
test for SARS-CoV-2 will be used.
Exclusion criteria:
PPE of health personnel who have been in contact with patients without confirmation of
COVID-19 diagnosis.
Elimination Criteria: those patients who change the result of the positive viral load to
negative viral load.
Time-space coordinates:
The research will be carried out from May 15, 2020 and will be carried out in the CM / UTI /
UC rooms of the Hospital de Clínicas José de San Martín, in those patients with confirmed
pathology of COVID-19 until reaching the necessary number of 16 patients.
2.2. Ethical objections to the project. This project is carried out under the ethical
standards that govern human research in accordance with the National Law on Protection of
Personal Data No. 25,326 (Habeas Data Law) and the Declaration of Helsinki in its latest
version (Fortaleza 2013). The Bioethics and Teaching and Research Committee of the José de
San Martín Clinic Hospital have given their approval to carry out the study.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT04558125 -
Low-Dose Tenecteplase in Covid-19 Diagnosed With Pulmonary Embolism
|
Phase 4 | |
Recruiting |
NCT04410510 -
P2Et Extract in the Symptomatic Treatment of Subjects With COVID-19
|
Phase 2/Phase 3 | |
Active, not recruiting |
NCT04420676 -
Synbiotic Therapy of Gastrointestinal Symptoms During Covid-19 Infection
|
N/A | |
Completed |
NCT04419025 -
Efficacy of N-Acetylcysteine (NAC) in Preventing COVID-19 From Progressing to Severe Disease
|
Phase 2 | |
Completed |
NCT04425317 -
Detection of SARS-CoV-2 in Follicular Fluid and Cumulus-oocyte-complexes in COVID-19 Patients
|
N/A | |
Completed |
NCT04395911 -
Safety and Efficacy of SCD in AKI or ARDS Patients Associated With COVID-19 Infections
|
N/A | |
Completed |
NCT04526769 -
Detecting SARS-CoV-2 in Tears
|
||
Withdrawn |
NCT04456426 -
Characteristics of Patients With COVID-19 in Meta State, Colombia
|
||
Completed |
NCT04425720 -
Use of Remote Monitoring for COVID-19 Patient
|
N/A | |
Suspended |
NCT04385771 -
Cytokine Adsorption in Patients With Severe COVID-19 Pneumonia Requiring Extracorporeal Membrane Oxygenation
|
N/A | |
Completed |
NCT04419610 -
RAS and Coagulopathy in COVID19
|
Early Phase 1 | |
Completed |
NCT04546581 -
Inpatient Treatment of COVID-19 With Anti-Coronavirus Immunoglobulin (ITAC)
|
Phase 3 | |
Completed |
NCT04435327 -
Lung Damage Caused by SARS-CoV-2 Pneumonia (COVID-19)
|
||
Terminated |
NCT04530448 -
Coronavirus Induced Acute Kidney Injury: Prevention Using Urine Alkalinization
|
Phase 4 | |
Not yet recruiting |
NCT04524156 -
COVID-19 : Transcutaneous pO2 and pCO2 as Predictive Factors for Acute Respiratory Destress Syndrome in Patients Affected With SARS-Cov-2
|
N/A | |
Completed |
NCT04441710 -
Caregiver Serological Monitoring Extended Secondarily to Patients With the SARS-CoV-2 Coronavirus
|
||
Completed |
NCT04357834 -
WAVE. Wearable-based COVID-19 Markers for Prediction of Clinical Trajectories
|
||
Not yet recruiting |
NCT04392427 -
New Antiviral Drugs for Treatment of COVID-19
|
Phase 3 | |
Terminated |
NCT04614025 -
Open-label Multicenter Study to Evaluate the Efficacy of PLX-PAD for the Treatment of COVID-19
|
Phase 2 | |
Completed |
NCT04402957 -
LSALT Peptide vs. Placebo to Prevent ARDS and Acute Kidney Injury in Patients Infected With SARS-CoV-2 (COVID-19)
|
Phase 2 |